home / stock / ngmdf / ngmdf news


NGMDF News and Press, NuGen Medical Devices From 01/19/24

Stock Information

Company Name: NuGen Medical Devices
Stock Symbol: NGMDF
Market: OTC
Website: nugenmd.com

Menu

NGMDF NGMDF Quote NGMDF Short NGMDF News NGMDF Articles NGMDF Message Board
Get NGMDF Alerts

News, Short Squeeze, Breakout and More Instantly...

NGMDF - NuGen Receives Two Additional Sales Orders for InsuJet(TM) and Expands Distribution into Argentina, Chile, Costa Rica and Peru

Toronto, Ontario--(Newsfile Corp. - January 19, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to report that its distribution partner in Mexico, Science-Link Trading S...

NGMDF - NuGen Medical Signs 5-year Distribution Agreement for InsuJet(TM) with Verrue Consulting Group in Belgium

Toronto, Ontario--(Newsfile Corp. - December 19, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of December 17, 2023, Verrue Consulting Group BV (" ...

NGMDF - NuGen Medical Signs 5-Year Distribution Agreement for InsuJet(TM) with Advance Medical Life Co.

Toronto, Ontario--(Newsfile Corp. - December 14, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that, as of December 12, 2023, Advance Medical Life Co. Ltd....

NGMDF - NuGen Medical Devices names veteran medical executive Ian Heynen as Chief Executive Officer

(NewsDirect) NuGen Medical Devices CEO Ian Heynen joined Steve Darling from Proactive to discuss his appointment and share some exciting news regarding the company's needle-free InsuJet injection device. Heynen brings a wealth of experience to his role as CEO, with a strong track reco...

NGMDF - InsuJet(TM) Registered as a Medical Device in Mexico

Second Bulk Sale for InsuJet(TM) Now Paid in Full Toronto, Ontario--(Newsfile Corp. - November 13, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") is pleased to announce the Mexican government has completed the registration of NuGen's needle-free InsuJet™ in...

NGMDF - Diabetic Lifestyle Subscription Business Launched on Shopify as NuGen's B2C Business Vertical

www.insujet.com - a diabetic e-commerce store Toronto, Ontario--(Newsfile Corp. - November 7, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce the official l...

NGMDF - MedTech Industry Leader Ian Heynen Commences CEO Role at NuGen

Toronto, Ontario--(Newsfile Corp. - November 2, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to report that Mr. Ian Heynen has commenced his role as the Company's new...

NGMDF - NuGen Medical appoints Ian Heynen as CEO

2023-10-12 07:34:23 ET More on NuGen Medical Devices: Financial information for NuGen Medical Devices Inc. For further details see: NuGen Medical appoints Ian Heynen as CEO

NGMDF - NuGen Medical Appoints Industry Leader Ian Heynen as CEO

Toronto, Ontario--(Newsfile Corp. - October 12, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle free devices to administer therapeutics subcutaneously, is pleased to announce it has appointed Mr. Ian Heynen as the Company's new Chief Ex...

NGMDF - Semaglutide - Ozempic(R) is Chemically Stable When Administered Using NuGen's Needle Free InsuJet(TM) Device

Toronto, Ontario--(Newsfile Corp. - October 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the " Company " or " NuGen ") a leading developer of needle free devices to administer therapeutics subcutaneously, today presented new data from a preliminary trial that semaglutide (Ozempic®) i...

Previous 10 Next 10